InsidersTradesSigma
Follow the NIKA PHARMACEUTICALS, INC stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €534.8m. The latest transaction was filed on 19 March 2025 (Cession). Among the most active insiders: NIKA PHARMACEUTICALS, INC. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
NIKA PHARMACEUTICALS, INC 是一家专注于药品开发和商业化的公司。该公司在纳斯达克上市，股票代码为XNAS。